Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
22%
OVERLAP
BY WEIGHT
20
# OF OVERLAPPING
HOLDINGS
FTXH
50
HOLDINGS
41%
ALSO IN HELX
HELX
66
HOLDINGS
35%
ALSO IN FTXH
SECTOR DRIFT (FTXH minus HELX)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in HELX |
Overlap | |
|---|---|---|---|---|
| ELI LILLY & CO | 7.6% | 3.0% | 3.0% | |
| VERTEX PHARMACEUTICALS INC | 3.2% | 2.8% | 2.8% | |
| UNITED THERAPEUTICS CORP | 2.6% | 3.8% | 2.6% | |
| REGENERON PHARMACEUTICALS | 2.8% | 1.9% | 1.9% | |
| MEDPACE HOLDINGS, INC. | 1.6% | 2.1% | 1.6% | |
FTXH Overweight Relative to HELX
| ABBVIE INC | 7.5% | |
| JOHNSON & JOHNSON | 7.1% | |
| MERCK & CO. INC. | 7.1% | |
| BRISTOL-MYERS SQUIBB CO | 6.4% | |
| ELI LILLY & CO | 4.6% | |
| VIATRIS, INC. | 3.9% | |
| BIOGEN IDEC INC | 3.5% | |
| CARDINAL HEALTH INC | 3.4% | |
| AMGEN INC | 3.3% | |
| PFIZER INC | 3.0% |
FTXH Underweight Relative to HELX
| GUARDANT HEALTH, INC. | -8.1% | |
| NATERA INC | -7.0% | |
| KRYSTAL BIOTECH, INC. | -6.0% | |
| LIGAND PHARMACEUTICALS-CL B | -3.7% | |
| ADAPTIVE BIOTECHNOLOGIES CORP. | -3.6% | |
| BRIDGEBIO PHARMA, INC. | -3.4% | |
| ASTRAZENECA PLC | -2.7% | |
| INSMED INC | -2.4% | |
| CORTEVA INC | -2.3% | |
| TRAVERE THERAPEUTICS, INC. | -1.9% |